Aesthetic Medical International Holdings Group

General Information
Business:

 

We are a leading provider of aesthetic medical services in China. Leveraging over 20 years of clinical experience, we provide one-stop aesthetic service offerings that includes (i) surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation and liposuction, (ii) non-surgical aesthetic treatments which comprise minimally invasive treatments and energy-based treatments such as laser, ultrasound and ultraviolet light treatments, and (iii) other aesthetic services such as cosmetic dentistry, as well as general medical services. According to Frost & Sullivan, we are the third largest private aesthetic medical services provider in China in terms of revenue in 2018. The total aesthetic medical services market in China, which includes both public and private services providers, grew at a CAGR of 23.6% from RMB52.1 billion in 2014 to RMB121.7 billion in 2018 and is expected to grow to RMB360.1 billion in 2023, representing a CAGR of 24.2% from 2018 to 2023, according to Frost & Sullivan.

Industry: SPECIALTY OUTPATIENT FACILITIES
Employees: 1687
Founded: 1997
Contact Information
Address 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China
Phone Number +86 (755) 2559 8065
Web Address http://www.pengai.com.cn
View Prospectus: Aesthetic Medical International Holdings Group
Financial Information
Market Cap $850.1mil
Revenues $111.6 mil (last 12 months)
Net Income $-26.5 mil (last 12 months)
IPO Profile
Symbol AIH
Exchange NASDAQ
Shares (millions): 2.5
Price range $12.00 - $12.00
Est. $ Volume $30.0 mil
Manager / Joint Managers Cantor/ Haitong International/ Prime Number Capital
CO-Managers Maxim Group/ CMBI/ Zinvest Global
Expected To Trade: 10/25/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change